- lung (LCNEC)
Extrapulmonary small cell
carcinomas (ESCC or EPSCC)
Gastroenteropancreatic neuroendocrine tumors (GEP-NET)
Foregut GEP-NET (foregut tumors...
- is
indicated for the
treatment of
somatostatin receptor-positive
gastroenteropancreatic neuroendocrine tumors (GEP-NETs),
including foregut, midgut, and...
- a type of
neuroendocrine tumor,
representing about one-third of
gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Many
PanNETs are benign, while...
-
primarily by
tumors of the
parathyroid glands (95% of cases),
endocrine gastroenteropancreatic (GEP)
tract (30–80% of cases), and
anterior pituitary (15–90% of...
- well or
moderately differentiated,
locally advanced or
metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs). It is used for
polycystic liver...
- Name
Treatment of
Route of
administration In-vitro / in-vivo 177Lu-DOTA-TATE
gastroenteropancreatic neuroendocrine tumors (GEP-NETs) IV In-vivo...
- 2010). "Peptide
receptor radionuclide therapy in
patients with
gastroenteropancreatic neuroendocrine tumors".
Seminars in
Nuclear Medicine. 40 (2): 78–88...
-
therapy (approved by the FDA in 2018)
specifically for
patients with
gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that have
somatostatin hormone...
- patient's needs. In most
cases PRRT is used for
cancers of the
gastroenteropancreatic and
bronchial tracts, and in some
cases phaeochromocytoma, paraganglioma...
-
Caplin ME, et al. (January 2012). "Guidelines for the
management of
gastroenteropancreatic neuroendocrine (including carcinoid)
tumours (NETs)". Gut. 61 (1):...
